A study of microbially fabricated bio-conjugated quantum dots for pico-molar sensing of H2O2 and glucose

l-cysteine capped MoS2 QDs for dual-channel imaging and superior Fe3+ ion sensing in biological systems

MoS2 quantum dots (MQDs) with an average size of 1.9 ± 0.7 nm were synthesized using a microwave-assisted method. Absorbance studies confirmed characteristic transitions of MoS2, with absorption humps at 260-280 nm and 300-330 nm, and a band gap of 3.6 ± 0.1 eV. Fluorescence emission studies showed dominant blue and some green emissions under 315 nm excitation, with an absolute quantum yield of ∼9%. The MQDs exhibited fluorescence stability over time after repeated quenching cycles across various pH and media systems. In vitro toxicity tests indicated cytocompatibility, with around 80% cell survival at 1000 mg L-1. Confocal imaging demonstrated significant uptake and vibrant fluorescence in cancerous and non-cancerous cell lines. The MQDs showed strong selectivity towards Fe3+ ions, with a detection limit of 27.61 ± 0.25 nM. Recovery rates for Fe3+ in phosphate buffer saline (PBS) and simulated body fluid (SBF) systems were >97% and >98%, respectively, with a relative standard deviation (RSD) within 3%, indicating precision. These findings suggest that MQDs have high potential for diagnostic applications involving Fe3+ detection due to their fluorescence stability, robustness, enhanced cell viability, and dual-channel imaging properties.

Recent progress in MoS2 nanostructures for biomedical applications: Experimental and computational approach

In the category of 2D materials, MoS2 a transition metal dichalcogenide, is a novel and intriguing class of materials with interesting physicochemical properties, explored in applications ranging from cutting-edge optoelectronic to the frontiers of biomedical and biotechnology. MoS2 nanostructures an alternative to heavy toxic metals exhibit biocompatibility, low toxicity and high stability, and high binding affinity to biomolecules. MoS2 nanostructures provide a lot of opportunities for the advancement of novel biosensing, nanodrug delivery system, electrochemical detection, bioimaging, and photothermal therapy. Much efforts have been made in recent years to improve their physiochemical properties by developing a better synthesis approach, surface functionalization, and biocompatibility for their safe use in the advancement of biomedical applications. The understanding of parameters involved during the development of nanostructures for their safe utilization in biomedical applications has been discussed. Computational studies are included in this article to understand better the properties of MoS2 and the mechanism involved in their interaction with biomolecules. As a result, we anticipate that this combined experimental and computational studies of MoS2 will inspire the development of nanostructures with smart drug delivery systems, and add value to the understanding of two-dimensional smart nano-carriers.

Nanomaterials-assisted metabolic analysis toward in vitro diagnostics

In vitro diagnostics (IVD) has played an indispensable role in healthcare system by providing necessary information to indicate disease condition and guide therapeutic decision. Metabolic analysis can be the primary choice to facilitate the IVD since it characterizes the downstream metabolites and offers real-time feedback of the human body. Nanomaterials with well-designed composition and nanostructure have been developed for the construction of high-performance detection platforms toward metabolic analysis. Herein, we summarize the recent progress of nanomaterials-assisted metabolic analysis and the related applications in IVD. We first introduce the important role that nanomaterials play in metabolic analysis when coupled with different detection platforms, including electrochemical sensors, optical spectrometry, and mass spectrometry. We further highlight the nanomaterials-assisted metabolic analysis toward IVD applications, from the perspectives of both the targeted biomarker quantitation and untargeted fingerprint extraction. This review provides fundamental insights into the function of nanomaterials in metabolic analysis, thus facilitating the design of next-generation diagnostic devices in clinical practice.

High-Performance, Nitrogen-Doped, Carbon-Nanotube-Based Electrochemical Sensor For Vitamin D3 Detection

With the fast changing lifestyle, vitamin D deficiency is becoming extremely common. Therefore, development of economical, efficient, and fast sensors for vitamin D is the need of the hour. Carbon-based nanomaterials are extensively explored in sensing of variety of biomolecules. In the present study, an antibody-free, highly sensitive, carbon-nanotube-based, highly responsive vitamin D3 sensor is reported. Nitrogen-doped carbon nanotubes are utilized to overcome the limiting factor of hydrophobic character of pure carbon. The synthesized N-doped CNTs showed a specific surface area of 24 m²/g. The surface charges of vitamin D3 and the vitamin D3/NCNT complex are found to be -20 and -6.4 mV, respectively, by zeta potential measurements. The sensor is able to deliver high performance in the concentration range of 0-10 nM, with a limit of detection of 16 pM. The response study indicated the sensitivity value as 0.000495 mA/cm² nM. The sensor is also able to show a higher selectivity toward vitamin D3 in comparison to other biomolecules. The long-term stability, reproducibility, good linear range, and ultralow detection capability of the sensor are also reported.

Graphene Quantum Dots-Based Electrochemical Biosensing Platform for Early Detection of Acute Myocardial Infarction

Heart failure resulting from acute myocardial infarction (AMI) is an important global health problem. Treatments of heart failure and AMI have improved significantly over the past two decades; however, the available diagnostic tests only give limited insights into these heterogeneous conditions at a reversible stage and are not precise enough to evaluate the status of the tissue at high risk. Innovative diagnostic tools for more accurate, more reliable, and early diagnosis of AMI are urgently needed. A promising solution is the timely identification of prognostic biomarkers, which is crucial for patients with AMI, as myocardial dysfunction and infarction lead to more severe and irreversible changes in the cardiovascular system over time. The currently available biomarkers for AMI detection include cardiac troponin I (cTnI), cardiac troponin T (cTnT), myoglobin, lactate dehydrogenase, C-reactive protein, and creatine kinase and myoglobin. Most recently, electrochemical biosensing technologies coupled with graphene quantum dots (GQDs) have emerged as a promising platform for the identification of troponin and myoglobin. The results suggest that GQDs-integrated electrochemical biosensors can provide useful prognostic information about AMI at an early, reversible, and potentially curable stage. GQDs offer several advantages over other nanomaterials that are used for the electrochemical detection of AMI such as strong interactions between cTnI and GQDs, low biomarker consumption, and reusability of the electrode; graphene-modified electrodes demonstrate excellent electrochemical responses due to the conductive nature of graphene and other features of GQDs (e.g., high specific surface area, π-π interactions with the analyte, facile electron-transfer mechanisms, size-dependent optical features, interplay between bandgap and photoluminescence, electrochemical luminescence emission capability, biocompatibility, and ease of functionalization). Other advantages include the presence of functional groups such as hydroxyl, carboxyl, carbonyl, and epoxide groups, which enhance the solubility and dispersibility of GQDs in a wide variety of solvents and biological media. In this perspective article, we consider the emerging knowledge regarding the early detection of AMI using GQDs-based electrochemical sensors and address the potential role of this sensing technology which might lead to more efficient care of patients with AMI.

Current advances in bio-fabricated quantum dots emphasising the study of mechanisms to diversify their catalytic and biomedical applications

Quantum dots (QDs), owing to their single atom-like electronic structure due to quantum confinement, are often referred to as artificial atoms. This unique physical property results in the diverse functions exhibited by QDs. A wide array of applications have been achieved by the surface functionalization of QDs, resulting in exceptional optical, antimicrobial, catalytic, cytotoxic and enzyme inhibition properties. Ordinarily, traditionally prepared QDs are subjected to post synthesis functionalization via a variety of methods, such as ligand exchange or covalent and non-covalent conjugation. Nevertheless, solvent toxicity, combined with the high temperature and pressure conditions during the preparation of QDs and the low product yield due to multiple steps in the functionalization, limit their overall use. This has driven scientists to investigate the development of greener, environmental friendly and cost-effective methods that can circumvent the complexity and strenuousness associated with traditional processes of bio-functionalization. In this review, a detailed analysis of the methods to bio-prepare pre-functionalized QDs, with elucidated mechanisms, and their application in the areas of catalysis and biomedical applications has been conducted. The environmental and health and safety aspects of the bio-derived QDs have been briefly discussed to unveil the future of nano-commercialization.